We tested this possibility by first establishing skin microbiota of Sox13-/- mice at 3 and 6 mo by 16S rRNA sequencing, followed by assessment of antibiotic treatment (Abx) on AD onset and progression. This evidence concerns the gene SOX13 and Alzheimer disease.